Miromatrix Medical Inc. (MIRO)
Miromatrix Medical Statistics
Share Statistics
Miromatrix Medical has 27.42M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 27.42M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 19.61M |
| Failed to Deliver (FTD) Shares | 48 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 11.66K, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 11.66K |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.07 and the forward PE ratio is null. Miromatrix Medical's PEG ratio is -0.18.
| PE Ratio | -2.07 |
| Forward PE | n/a |
| PS Ratio | 65 |
| Forward PS | n/a |
| PB Ratio | 2.37 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | -0.18 |
Enterprise Valuation
Miromatrix Medical has an Enterprise Value (EV) of 60.32M.
| EV / Sales | 63.26 |
| EV / EBITDA | -2.02 |
| EV / EBIT | -2.26 |
| EV / FCF | -2.17 |
Financial Position
The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.52 |
| Quick Ratio | 5.36 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | -0.12 |
| Debt / FCF | -0.13 |
| Interest Coverage | -633.66 |
Financial Efficiency
Return on Equity is -114.94% and Return on Invested Capital is -102.14%.
| Return on Equity | -114.94% |
| Return on Assets | -86.32% |
| Return on Invested Capital | -102.14% |
| Revenue Per Employee | $12.55K |
| Profits Per Employee | $-394.84K |
| Employee Count | 76 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.62 |
Taxes
| Income Tax | 47.84K |
| Effective Tax Rate | -0.16% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.01, so Miromatrix Medical's price volatility has been higher than the market average.
| Beta | 0.01 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 2.87 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 75.32 |
| Average Volume (20 Days) | 163.02K |
Income Statement
In the last 12 months, Miromatrix Medical had revenue of 953.47K and earned -30.01M in profits. Earnings per share was -1.45.
| Revenue | 953.47K |
| Gross Profit | 453.47K |
| Operating Income | -30.25M |
| Net Income | -30.01M |
| EBITDA | -29.91M |
| EBIT | -30.03M |
| Earnings Per Share (EPS) | -1.45 |
Balance Sheet
The company has 5.21M in cash and 3.55M in debt, giving a net cash position of 1.66M.
| Cash & Cash Equivalents | 5.21M |
| Total Debt | 3.55M |
| Net Cash | 1.66M |
| Retained Earnings | -104.01M |
| Total Assets | 23.42M |
| Working Capital | 12.23M |
Cash Flow
In the last 12 months, operating cash flow was -26.68M and capital expenditures -1.06M, giving a free cash flow of -27.75M.
| Operating Cash Flow | -26.68M |
| Capital Expenditures | -1.06M |
| Free Cash Flow | -27.75M |
| FCF Per Share | -1.34 |
Margins
Gross margin is 47.56%, with operating and profit margins of -3172.17% and -3147.22%.
| Gross Margin | 47.56% |
| Operating Margin | -3172.17% |
| Pretax Margin | -3142.21% |
| Profit Margin | -3147.22% |
| EBITDA Margin | -3137.2% |
| EBIT Margin | -3172.17% |
| FCF Margin | -2909.97% |
Dividends & Yields
MIRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -48.42% |
| FCF Yield | -44.77% |
Analyst Forecast
Currently there are no analyst rating for MIRO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -3.66 |
| Piotroski F-Score | 3 |